Combination of active components enhances the efficacy of prunella in prevention and treatment of lung cancer

Molecules

Volumn 15, Issue 11, 2010, Pages 7893-7906

  Feng, Liang ^a,b   Jia, Xiao Bin ^b   Jiang, Jun ^b,d   Zhu, Mao Mao ^c   Chen, Yan ^b   Tan, Xiao Bin ^b   Shi, Feng ^b  

^a KEY LABORATORY OF NEW DRUG DELIVERY SYSTEM OF CHINESE MATERIA MEDICA   (China)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^c Rudong County Grain Bureau   (China)

^d Zhenjiang Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Active components combination mode; Efficacy material basis; Lung cancer; Prevention; Prunella

Indexed keywords

EID: 78649471451     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15117893     Document Type: Article

References (24)

1. Kano, S. Artemisinin-based combination therapies and their introduction in Japan. Infect. Chemother. 2010, in press.
2. Kim, Y.J.; Chung, J.W.; Lee, S.J.; Choi, K.S.; Kim, J.H.; Hahm, K.B. Progression from chronic atrophic gastritis to gastric cancer; tangle, toggle, tackle with Korea red ginseng. J. Clin. Biochem. Nutr. 2010, 46,195-204.
3. Cardini, F.; Lesi, G.; Lombardo, F.; Van der, S.C. MSCG - Menopause Survey Collaborative Group. The use of Complementary and Alternative Medicine by women experiencing menopausal symptoms in Bologna. BMC Women's Health 2010, 10, 7.
4. Innocenti, G.; Dall'Acqua, S.; Scialino, G.; Banfi, E.; Sosa, S.; Gurung, K.; Barbera, M.; Carrara, M. Chemical composition and biological properties of Rhododendron anthopogon essential oil. Molecules 2010, 15, 2326-2338.
5. Yan, Y.; Cook, J.; McQuillan, J.; Zhang, G.; Hitzman, C.J.; Wang, Y.; Wiedmann, T.S.; You, M. Chemopreventive Effect of Aerosolized Polyphenon E on Lung Tumorigenesis in A/J Mice. Neoplasia 2007, 9, 401-405.
6. Gaudineau, C.; Beckerman, R.; Sarah, W.; Karine, A. Inhibition of human P450 enzymes by multiple constituents of the Ginkgo biloba extract. Biochem. Biophys. Res. Commun. 2004, 318, 1072-1078.
7. Chen, Z.Q.; Lin, F.F.; Ren, L.; Yin, J.H.; Xie, H.P. Fast determination of the release degree of compound sulfamethoxazole tablets by using circulation release system combined with ultraviolet spectral net analyte signal method. Anal. Sci. 2009, 25, 1461-1465.
8. Schwabe, K.P; Karlsrube DE. Extract from Ginkgo biloba leaves, its method of preparation and pharmaceuticals containing the extract. US Patent 5399348, 21 March 1995
9. Zheng, X.Y. Pharmacopoeia of the People's Republic of China; Chemical Industry Press: Beijing, China, 2005; Volume 2.
10. Cheung, H.Y.; Zhang, Q.F. Enhanced analysis of triterpenes, flavonoids and phenolic compounds in Prunella vulgaris L. by capillary zone electrophoresis with the addition of running buffer modifiers. J. Chromatogr. A. 2008, 1213, 231-238.
11. Lee, K., II; Kim, D.H.; Lee, S.Y.; Kim, K.R.; Choi, S.U.; Hong, J.K.; Lee, J.H.; Park, Y.H.; Lee, K.R. Triterpenoic Acids of Prunella vulgaris var. lilacina and Their Cytotoxic Activities In vitro. Arch. Pharm. Res. 2008, 31, 1578-1583.
12. Jitka, P.; Milan, K.; Jaromír, S. Biological Activities of Prunella vulgaris Extract. Phytother. Res. 2003, 17, 1082-1087.
13. Psotova, J.; Svobodova, A.; Kolarova, H.; Walterova, D. Photoprotective properties of Prunella vulgaris and rosmarinic acid on human keratinocytes. J. Photochem. Photobiol. B: Biol. 2006, 84, 167-174.
14. Han, E.H.; Choi, J.H.; Hwang, Y.P.; Park, H,J.; Choi, C.Y.; Chung, Y.C.; Seo, J.K.; Jeong, H.G. Immunostimulatory activity of aqueous extract isolated from Prunella vulgaris. Food Chem. Toxicol. 2009, 47, 62-69.
15. Feng, L.; Jia, X.B.; Shi, F.; Chen, Y. Identification of two polysaccharides from Prunella vulgaris L. and evaluation on their anti-Lung adenocarcinoma activity. Molecules 2010, 15, 5093-5103.
16. Choi, J.H.; Han, E.H.; Hwang, Y.P.; Choi, J.M.; Choi, C.Y.; Chung, Y.C.; Seo, J.K.; Jeong, H.G. Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kB-dependent MMP-9 expression. Food Chem. Toxicol. 2010, 48, 564-571.
17. Lee, H.; Lin, J.Y. Antimutagenic activity of extracts from anticancer drugs in Chinese medicine. Mutat. Res. 1988, 204, 229-234.
18. Horikawa, K.; Mohri, T.; Tanaka, Y. Moderate inhibition of mutagenicity and carcinogenicity of benzo[a] pyrene,1,6-dinitropyrene and 3,9-dinitrofluoranthene by Chinese medicinal herbs. Mutagenesis 1994, 9, 523-526.
19. Li, J.; Zhao, Y.F.; Yuan, X.Y.; Xu, J.X.; Gong, P. Synthesis and anticancer activities of novel 1,4-disubstituted phthalazines. Molecules 2006, 11, 574-582. (Pubitemid 44252747)
20. Izycka, A.; Jabłońska, E.; Izycki, T.; Chyczewska, E. Expression of L-selectin on the surface of neutrophils stimulated by TNF-alpha and level of sL-selectin in serum of patients with lung cancer. Pol. Merkur. Lekarski. 2005, 18, 62-65.
21. Chosa, N.; Kyakumoto, S.; Kito, N.; Kamo, M.; Sato, N. Mechanism of Fas-mediated cell death and its enhancement by TNF-alpha in human salivary gland adenocarcinoma cell line HSG. Eur. J. Oral Sci. 2004, 112, 338-346.
22. Wan, L.; Cao, D.; Zeng, J.; Yan, R.; Pizzorno, G. Modulation of uridine phosphorylase gene expression by tumor necrosis factor-alpha enhances the antiproliferative activity of the capecitabine intermediate 5?-deoxy-5- fluorouridine in breast cancer cells. Mol. Pharmacol. 2006, 69, 1389-1395.
23. Kuroda, K.; Miyata, K.; Tsutsumi, Y.; Tsunoda, S.; Nishimura, K.; Mitsuishi, Y.; Nakagawa, S.; Mayumi, T. Preferential activity of wild-type and mutant tumor necrosis factor-alpha against tumor-derived endothelial-like cells. Jpn. J. Cancer Res. 2000, 91, 59-67.
24. Ohtani, T.; Nakamura, T.; Toda, K.; Furukawa, F. Cyclophosphamide enhances TNF alpha-induced apoptotic cell death in murine vascular endothelial cell. FEBS Lett. 2006, 580, 1597-1600.